Sign In
Buy CHRS
$1.46
-0.0200 (-1.35%)
At Close: Jun 23, 2026
IBD Rating Upgrades: Coherus Biosciences Flashes Improved Price Strength
12:00am, Wednesday, 06'th May 2020Coherus BioSciences Management to Present at BofA Securities 2020 Health Care Conference
01:30pm, Monday, 04'th May 2020
REDWOOD CITY, Calif., May 04, 2020 -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will make a virtual presentation at BofA.
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Mizuho Securities Reaffirms Their Hold Rating on Amgen (AMGN)
09:44pm, Thursday, 30'th Apr 2020
In a report released today, Salim Syed from Mizuho Securities reiterated a Hold rating on Amgen (AMGN), with a price target of $215.00. The company's
Mizuho Securities Reaffirms Their Hold Rating on Amgen (AMGN)
09:43pm, Thursday, 30'th Apr 2020
In a report released today, Salim Syed from Mizuho Securities reiterated a Hold rating on Amgen (AMGN – Research Report),
Coherus BioSciences (CHRS) Earnings Expected to Grow: Should You Buy?
04:34pm, Thursday, 30'th Apr 2020
Coherus BioSciences (CHRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Coherus BioSciences (CHRS) Earnings Expected to Grow: Should You Buy?
04:34pm, Thursday, 30'th Apr 2020
Coherus BioSciences (CHRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
H.C. Wainwright Remains a Buy on Coherus Biosciences (CHRS)
11:16am, Thursday, 30'th Apr 2020
In a report released today, Douglas Tsao from H.C. Wainwright maintained a Buy rating on Coherus Biosciences (CHRS), with a price target of $30.00. The
H.C. Wainwright Remains a Buy on Coherus Biosciences (CHRS)
11:15am, Thursday, 30'th Apr 2020
In a report released today, Douglas Tsao from H.C. Wainwright maintained a Buy rating on Coherus Biosciences (CHRS – Research
Coherus Biosciences (CHRS) Set to Announce Earnings on Thursday
08:54am, Thursday, 30'th Apr 2020
Coherus Biosciences (NASDAQ:CHRS) will be releasing its earnings data after the market closes on Thursday, May 7th. Analysts expect Coherus Biosciences to post earnings of $0.49 per share for the quar
Coherus BioSciences (CHRS) Earnings Expected to Grow: Should You Buy?
12:00am, Thursday, 30'th Apr 2020Mizuho Securities Sticks to Their Buy Rating for Gilead Sciences (GILD)
02:02pm, Wednesday, 29'th Apr 2020
In a report released today, Salim Syed from Mizuho Securities maintained a Buy rating on Gilead Sciences (GILD), with a price target of $81.00. The
Mizuho Securities Sticks to Their Buy Rating for Gilead Sciences (GILD)
02:02pm, Wednesday, 29'th Apr 2020
In a report released today,
Salim Syed
from Mizuho Securities maintained a
Buy
rating on Gilead Sciences (
GILD
–
Research Report
), with a price target of
$81.00
. The company’s shares closed las
Southwest AirlinesAdds to the Surge in Convertible BondDeals
07:25pm, Tuesday, 28'th Apr 2020
(Bloomberg) -- Southwest Airlines Co. launched a billion-dollar convertible offering Tuesday morning, adding to the massive pile of paper sold in 2020.Some $25 billion in bonds with embedded stock opt
